ASRs and RUOs Market (Product Type: Analyte Specific Reagents and Research Use Only Products; and End-user by Application: Human Healthcare, Veterinary, Environmental, Food Industry, Academic & Research Institutes, and Others) - U.S. Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2030

The US ASRs and RUOs market gathered revenue around USD 6.2 billion in 2021 and market is set to grow USD 10.2 billion by the end of 2030 and is estimated to expand at a modest CAGR of 8.2% during the prediction period 2022 to 2030.

Growth Factors:

The ASRs and RUOs market in the U.S. has witnessed robust growth in the last decade. Technological developments in the field of biotechnology and life sciences drive the market in the country. Advancement in technology has expanded the application areas of biotechnology and life sciences, thereby fueling the growth of the ASRs and RUOs market.

Rise in prevalence of infectious diseases, cancer, and hereditary diseases increases the demand for diagnostic tools. Surge in use of diagnostic tools such as polymerase chain reaction (PCR), hematology, and immunoassay augments the market.

Technological advancements in the field of cell and tissue culture has increased the usage of ASRs in the areas of microbiology, antibiotics, and diagnostic testing. Moreover, ongoing research & development and increase in demand for innovative and breakthrough technologies propel the ASRs and RUOs market in the U.S.

U.S. ASRs and RUOs Market: Overview

• Analyte specific reagents (ASR) are antibodies, both polyclonal and monoclonal, specific receptor proteins, ligands, nucleic acid sequences, and similar reagents which, through specific binding or chemical reaction with substances in a specimen, are intended for use in a diagnostic application for identification and quantification of an individual chemical substance or ligand in biological specimens.
• Research use only (RUO) means research that is not for profit, internal research, or research for evaluation purposes. Research use only specifically excludes using the product by the licensee in any activity for consideration.
• Technological advancements are anticipated to drive the ASRs and RUOs market in the U.S. during the forecast period

Report Scope of the ASRs and RUOs Market

U.S. ASRs and RUOs Market – Scope of Report

Nova one advisor’s report on the ASRs and RUOs market in the U.S. studies the current as well as future prospects of the ASRs and RUOs market in the U.S. Stakeholders of the report include companies and intermediaries engaged in provision of ASRs and RUOs as well as new players planning to enter the market.

The report provides market value in terms of US$ Mn for the period from 2017 to 2030, along with the compound annual growth rate (CAGR %) from 2022 to 2030 are provided for all segments, considering 2021 as the base year and 2017–2020 as the historical years.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the ASRs and RUOs market in the U.S.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the ASRs and RUOs market in the U.S.

This report comprises an elaborate executive summary, along with a market snapshot providing overall information of various segments considered in the scope of the study. This section also provides the overall information and data analysis of the ASRs and RUOs market in the U.S. with respect to the leading market segments based on product type and end-user by application.

The ASRs and RUOs market in the U.S. has been studied based on major segments and their regional as well as national markets.

The report delves into the competition landscape of the ASRs and RUOs market in the U.S. Key players operating in the ASRs and RUOs market in the U.S. have been identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the ASRs and RUOs market in the U.S. profiled in this report.

Increased Importance of Diagnostic Testing with ASRs During COVID-19

ASRs are playing an instrumental role in early development and regulation of diagnostic testing for COVID-19. Such findings are translating into revenue opportunities for healthcare stakeholders. Diagnostic testing is a critical part of the public health response and clinical management of COVID-19, the disease caused by the SARS-CoV-2 virus. In an effort to facilitate the expansion of testing capacity as the first cases of community spread were confirmed in the United States, the Food and Drug Administration (FDA) announced a new COVID 19 diagnostics policy. The new policy, issued via agency guidance and effective immediately, allowed certain laboratories that had developed & validated their own COVID-19 diagnostic to begin to use the test prior to receiving an Emergency Use Authorization (EUA) from the agency.

Technological Advancements Help Boost Experiments with RUOs

ASRs are antibodies, both polyclonal and monoclonal, specific receptor proteins, ligands, nucleic acid sequences, and similar reagents, which, through specific binding or chemical reaction with substances in a specimen, are intended for use in a diagnostic application for identification & quantification of an individual chemical substance or ligand in biological specimens.

Research use only (RUO) means research that is not for profit, internal research, or research for evaluation purposes. Research use only specifically excludes using the product by the licensee in any activity for consideration. According to Nova one advisor, the U.S. ASRs and RUOs market is projected to expand at a modest CAGR during the forecast period. Technological advancements are anticipated to drive the U.S. ASRs and RUOs market during the forecast period.

Rise in Prevalence of Infectious Diseases Triggering Demand for ASRs

The U.S. ASRs and RUOs market has witnessed robust growth in the last decade. Technological developments in the field of biotechnology and life sciences are steering the growth of the market. Advancement in technology has expanded the application areas of biotechnology and life sciences, thereby fueling revenue growth of the U.S. ASRs and RUOs market.

The rise in prevalence of infectious diseases, cancer, and hereditary diseases is boosting the demand for diagnostic tools. The surge in use of diagnostic tools such as polymerase chain reaction, hematology, and immunoassay are augmenting the growth of the market.

Technological advancements in the field of cell and tissue culture has increased the usage of ASRs in the areas of microbiology, antibiotics, and diagnostic testing. Moreover, ongoing research & development (R&D) and increase in demand for innovative and breakthrough technologies are propelling income avenues in the U.S. ASRs and RUOs market.

Use of RUOs to Develop Medical Knowledge Related to Human Diseases

RUO means an in-vitro diagnostic product that is in the laboratory research phase of development and is being shipped or delivered for an investigation. Certain products, such as instruments, systems, and reagents, are considered under for research use only products segment.

These products are used to carry out research and not the object of the research. These include products intended for use in discovering and developing medical knowledge related to human diseases and conditions. For instance, instruments and reagents intended for use in research attempting to isolate a gene linked with a particular disease could be labeled for research use only when such instruments & reagents are not intended to produce results for clinical use.

Increase in Usage of ASRs in Diagnostic Applications: Major Driver

• Increase in usage of ASRs in diagnostic testing helps health care providers screen for or monitor specific diseases or conditions. It also helps assess patient health to make clinical decisions for patient care.
• For instance, altona diagnostics’s RealStar ASR Adenovirus Probe and the RealStar ASR Adenovirus Primer are analyte specific reagents (ASR) that are used for in vitro detection of human adenovirus (HAdV) specific DNA by real-time polymerase chain reaction (PCR)
• Increase in usage of ASRs in various diagnostic applications is expected to boost the growth of the ASRs and RUOs market in the U.S. during the forecast period

Some of the prominent players in the ASRs and RUOs Market include:

• BioLegend, Inc.
• ELITechGroup
• BD
• bioMerieux, Inc.
• Genetic Signatures
• Thermo Fisher Scientific, Inc.
• Danaher Corporation
• DiaSorin Molecular LLC
• LGC Biosearch Technologies
• altona Diagnostics GmbH
• QIAGEN

Segments Covered in the Report

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at US, regional, and country level for the period of 2017 to 2030 and covers subsequent region in its scope:

• By Product Type
• Analyte Specific Reagents
• Research Use Only Products
• By End-user by Application
• Human Healthcare
• Veterinary
• Environmental
• Food Industry
• Academic & Research Institutes
• Others

By Geography

North America

• U.S.
• Canada

Key Points Covered in ASRs and RUOs Market Study:

• Growth of ASRs and RUOs in 2022
• Market Estimates and Forecasts (2017-2030)
•  Brand Share and Market Share Analysis
•  Key Drivers and Restraints Shaping Market Growth
•  Segment-wise, Country-wise, and Region-wise Analysis
•  Competition Mapping and Benchmarking
•  Recommendation on Key Winning Strategies
•  COVID-19 Impact on Demand for ASRs and RUOs and How to Navigate
•  Key Product Innovations and Regulatory Climate
•  ASRs and RUOs Consumption Analysis
•  ASRs and RUOs Production Analysis
•  ASRs and RUOs and Management